Primary angiosarcoma of the breast: a case report and review of the literature

J Med Assoc Thai. 2013 Mar;96(3):378-82.

Abstract

Primary angiosarcoma of the breast is rare. Therefore, no randomized trial can be used as guideline for diagnosis and treatment. To achieve optimal outcome, previous reports of case series are the sources for management with expected long-term survival. The objective of the present case report is to demonstrate complete pathologic response to neoadjuvant taxanes without recurrence after two years of follow-up.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast / pathology
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Breast Neoplasms / surgery
  • Combined Modality Therapy
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives*
  • Developing Countries*
  • Docetaxel
  • Female
  • Gemcitabine
  • Hemangiosarcoma / diagnosis*
  • Hemangiosarcoma / drug therapy*
  • Hemangiosarcoma / pathology
  • Hemangiosarcoma / surgery
  • Humans
  • Lymph Node Excision
  • Magnetic Resonance Imaging
  • Mammaplasty
  • Mastectomy, Radical
  • Middle Aged
  • Neoadjuvant Therapy*
  • Neoplasm Invasiveness
  • Surgical Flaps
  • Taxoids / administration & dosage*
  • Thailand

Substances

  • Taxoids
  • Deoxycytidine
  • Docetaxel
  • Gemcitabine